Quercetin and metabolic syndrome: A review

Phytother Res. 2021 Oct;35(10):5352-5364. doi: 10.1002/ptr.7144. Epub 2021 Jun 8.

Abstract

Metabolic syndrome (MetS) is a complex of diseases that lead to mortality due to the development of cardiovascular problems. Quercetin, as an important flavonoid, has various properties such as decreasing blood pressure, anti-hyperlipidemia, anti-hyperglycemia, anti-oxidant, antiviral, anticancer, anti-inflammatory, anti-microbial, neuroprotective, and cardio-protective effects. In this review article, we collected original articles from different sources such as Google Scholar, Medline, Scopus, and Pubmed, which is related to the effect of quercetin on the improvement of the signs of MetS, including elevated glucose level, hyperlipidemia, obesity, and blood pressure. According to these data, quercetin may also have a role in the management of metabolic disorders via different mechanisms such as increasing adiponectin, decreasing leptin, anti-oxidant activity, reduction of insulin resistance, the elevation of insulin level, and blocking of calcium channel. We have attempted to make some recommendations on the quercetin application in patients. However, it needs to do further clinical trials and more investigations to show the real clinical value of quercetin on metabolic syndrome.

Keywords: diabetes; dyslipidemia; hypertension; metabolic syndrome; obesity; quercetin.

Publication types

  • Review

MeSH terms

  • Adiponectin
  • Humans
  • Leptin
  • Metabolic Syndrome* / drug therapy
  • Obesity
  • Quercetin* / pharmacology
  • Quercetin* / therapeutic use

Substances

  • Adiponectin
  • Leptin
  • Quercetin